News of the WeekPatents

NIH Declines to March In on Pricing AIDS Drug

See allHide authors and affiliations

Science  13 Aug 2004:
Vol. 305, Issue 5686, pp. 926
DOI: 10.1126/science.305.5686.926b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


The National Institutes of Health (NIH) has rejected a controversial plea to use its legal muscle to rein in the spiraling cost of a widely used AIDS drug.